Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02334059 · ClinicalTrials.gov registry record · NA

Effect of Single Dose Ketamine and Magnesium on Postoperative Pain in Patients Undergoing Bariatric Surgery

A NA study, sponsored by Milton S. Hershey Medical Center.

Completed
Registry status
NA
Development phase
108
Enrollment target

NCT02334059 is a NA study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 108 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02334059, a NA study, has completed, sponsored by Milton S. Hershey Medical Center.

COMPLETED
Registry status
NA
Development phase
108 participants
Enrollment target

Study Summary

Opioid sparing analgesia is extremely important in the post-operative obese population. With more and more obese patients entering the operating room a multi-modal approach to analgesia is crucial. Finding effective alternatives to opioid therapy is the rationale of this proposal. Literature involving ketamine and magnesium in bariatric surgical patients is very sparse.

Interventions

  • OTHER Placebo
  • DRUG Ketamine
  • DRUG Ketamine plus magnesium

Trial Details

FieldValue
Enrollment Target 108 participants
Start Date 2015-11
Est. Completion 2019-03-13
Phase NA

Sponsor

Milton S. Hershey Medical Center

396 total trials

What the Registry Record Tells You About NCT02334059

The ClinicalTrials.gov registry entry for NCT02334059 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.

NCT02334059 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02334059 about?

NCT02334059 is a clinical study titled "Effect of Single Dose Ketamine and Magnesium on Postoperative Pain in Patients Undergoing Bariatric Surgery". Opioid sparing analgesia is extremely important in the post-operative obese population. With more and more obese patients entering the operating room a multi-modal approach to analgesia is crucial. Finding effective alternatives to opioid therapy is the rationale of this proposal. Literature involvi...

What is the current status of trial NCT02334059?

This trial is currently completed. It is a NA study. The enrollment target is 108 participants. The study started on 2015-11. Estimated completion is 2019-03-13.

What interventions are being tested in trial NCT02334059?

The interventions under investigation include: Placebo (OTHER), Ketamine (DRUG), Ketamine plus magnesium (DRUG).

Who is sponsoring clinical trial NCT02334059?

This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.